Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
JH-RE-06 CAS No.1361227-90-8
JH-RE-06 CAS No.1361227-90-8
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-4619 | 1mg | 410.00 | + Add to cart |
|
| R-R-4619 | 2mg | 710.00 | + Add to cart |
|
|
|
||||
Product description
JH-RE-06/CAS No.1361227-90-8, a potent REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POLζ. JH-RE-06 improves chemotherapy.
| Appearance | N/A |
|---|---|
| Molecular Weight | 468.72 |
| Purity | >90% |
| CAS | 1361227-90-8 |
| Formula | C20H16Cl3N3O4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of JH-RE-06 CAS No.1361227-90-8 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
